Microarray data further confirmed the positive OC therapeutic potential against LC at the gene levels, validating its c-MET/COX2 suppressive effects, along with the suppression of downstream network of genes associated with LC proliferation, migration and metastasis. The gene discussed is MET; the disease is laryngotracheoesophageal cleft.